EP1278569A1 — Apparatus and methods for the delivery of medicaments to the respiratory system
Assigned to Aerogen (Ireland) Ltd · Expires 2003-01-29 · 23y expired
What this patent protects
A nebulizing device for providing a nebulized fluid to a patient is provided. The nebulizing device may include a nebulizing element, a fluid delivery system, and at least one tube section. The fluid delivery system may be adapted to supply fluid to the nebulizing element. The at…
USPTO Abstract
A nebulizing device for providing a nebulized fluid to a patient is provided. The nebulizing device may include a nebulizing element, a fluid delivery system, and at least one tube section. The fluid delivery system may be adapted to supply fluid to the nebulizing element. The at least one tube section may define a delivery path to the patient. The delivery path may be defined by a distance between the nebulizing element and the patient. The delivery path may have a length of less than about 500 mm.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.